In a report released yesterday, Michael Carroll from RBC Capital reiterated a Buy rating on Medical Properties (NYSE: MPW), with a price target of $16. The company’s shares closed yesterday at $14.58, close to its 52-week high of $14.62.
According to TipRanks.com, Carroll is a 4-star analyst with an average return of 7.5% and a 77.1% success rate. Carroll covers the Financial sector, focusing on stocks such as Industrial Logistics Properties Trust, Government Properties Income Trust, and MedEquities Realty Trust.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Medical Properties with a $15.50 average price target, implying a 6.3% upside from current levels. In a report issued on August 2, SunTrust Robinson also reiterated a Buy rating on the stock with a $16 price target.
.
See today’s analyst top recommended stocks >>
Based on Medical Properties’ latest earnings release for the quarter ending June 30, the company reported a quarterly net profit of $112 million. In comparison, last year the company had a net profit of $73.32 million.
Based on the recent corporate insider activity of 20 insiders, corporate insider sentiment is neutral on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Medical Properties Trust, Inc. is a self-advised real estate investment trust, which engages in investing and owning net-leased healthcare facilities across the United States of America and selective foreign countries. It focuses on funding hospitals and other facilities where patients must be admitted by doctors.
